MARKET

CTSO

CTSO

Cytosorbents
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.77
+0.24
+4.34%
Opening 12:08 09/23 EDT
OPEN
5.50
PREV CLOSE
5.53
HIGH
5.79
LOW
5.48
VOLUME
101.11K
TURNOVER
--
52 WEEK HIGH
13.95
52 WEEK LOW
3.680
MARKET CAP
186.39M
P/E (TTM)
-10.8991
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CTSO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CTSO News

  • Analysts Expect Breakeven For Cytosorbents Corporation (NASDAQ:CTSO)
  • Simply Wall St..2d ago
  • MicroCap Rodeo Investor Conference - October 15 and 16, 2019, Austin Texas
  • ACCESSWIRE.4d ago
  • First Study to Evaluate CytoSorb in Cytokine Release Syndrome (CRS) Following CAR T-cell Immunotherapy to Commence
  • PR Newswire.09/16 12:00
  • World Sepsis Day 2019: CytoSorbents Highlights Its Support of Multiple Organizations In the Fight Against Sepsis
  • PR Newswire.09/13 11:08

More

Industry

Advanced Medical Equipment & Technology
-2.08%
Healthcare Equipment & Supplies
-0.89%

Hot Stocks

Name
Price
%Change

About CTSO

CytoSorbents Corporation is a critical care focused immunotherapy company. The Company is engaged in commercializing its product, CytoSorb, which is a blood purification technology with focus in preventing or treating multiple organ failure. The Company's purification technologies are based on biocompatible, porous polymer beads that remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. The Company's CytoSorb is an extracorporeal cytokine filter and is designed to reduce the cytokine storm that causes inflammation, organ failure and death in common critical illnesses, such as sepsis, burn injury, trauma, lung injury and pancreatitis. In addition, CytoSorb is used in other inflammatory conditions, such as cardiac surgery and autoimmune disease flares and cancer cachexia. It also has other products under development based upon its blood purification technology, including HemoDefend, ContrastSorb, DrugSorb, BetaSorb and others.
More

Webull offers Cytosorbents Corp (CTSO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.